The Efficacy and Safety of Aripiprazole and Paliperidone 1 and
3-Month Long-Acting Preparations During The Maintenance of Schizophrenia
in Clinical Practice
Running head: Aripiprazole and Paliperidone Long-Acting Forms
Gökçe Elif Sarıdoğan1,5, Neşet
Neşetoğlu2,6, Sema Ketenci3, Nazife
Gökçe Akpınar4, Mehmet Zafer Gören5,
Durişehvar Özer Ünal 2,6
1-Erenkoy Psychiatry Training and Research Hospital, Department of
Psychiatry
2 Istanbul University, Faculty of Pharmacy, Department of Analytical
Chemistry, Beyazıt/Istanbul
3- Atlas University Faculty of Medicine, Internal Medicine, Department
of Medical Pharmacology
4- Family Health Center No. 5 Gebze
5- Marmara University Faculty of Medicine, Department of Medical
Pharmacology
6- Istanbul University, Drug Research and Application Center, Beyazıt
/İstanbul
Corresponding author:
Gokce Elif SARIDOGAN, MD
University of Health Sciences Istanbul Erenkoy Mental Health and
Neurological Diseases Education and Research Hospital,
Sinan Ercan Cad. No:29, 34736 Kazasker, Erenkoy-Kadikoy/Istanbul/TURKEY.
GSM: +905325032797
drgokcesaridogan@gmail.com
The authors confirm that the Principal Investigator for this
observational study is Gokce Elif Saridogan and that they had direct
clinical responsibility for patients.